Arkolith/Insider Trading/FBIO/Form 4

Rosenwald Lindsay A MD

PRESIDENT, CEO & CHAIRMAN, Director, 10% OwnerFortress Biotech, Inc. (FBIO) · full profile →Form 4 · filed Sep 25, 2024
Net Buying
Open-Market Buys
$1.4M
Open-Market Sells
$0
Net Open-Market Flow
$1.4M
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 23, 2024Buy(P)763K$1.84$1.4M3.7M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 23, 2024Buy(P)763K$0.13$99K763K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-023957) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML